Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1–9 years: two phase 2 randomised, controlled, observer-blinded studies
Titel:
Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1–9 years: two phase 2 randomised, controlled, observer-blinded studies
Auteur:
Marshall, Helen S Vesikari, Timo Richmond, Peter C Wysocki, Jacek Szenborn, Leszek Beeslaar, Johannes Maguire, Jason D Balmer, Paul O'Neill, Robert Anderson, Annaliesa S Prégaldien, Jean-Louis Maansson, Roger Jiang, Han-Qing Perez, John L